Apester Ltd. entered into a letter of intent to acquire Sivota PLC (LSE:SIV) for $12 million in a reverse merger transaction on December 7, 2021. Apester Ltd entered into a conditional share purchase agreement to acquire Sivota PLC (LSE:SIV) for $12 million in a reverse merger transaction on January 25, 2022. The Company will own 53.9% of Apester's issued share capital on completion of the Transaction. On completion of the SPA, the Company will receive 14,947,409 Preferred Seed Shares in the capital of Apester for an aggregate price of $12 million. The Transaction is subject to the satisfaction of certain conditions precedent, including the entry into the definitive transaction documentation and passing at a General Meeting of the Company of such resolutions necessary to approve, implement and effect the transaction. The SPA is conditional upon, inter alia, the completion of a placing by Sivota, publication of a prospectus approved by the Financial Conduct Authority and readmission of Sivota's enlarged issued share capital to trading on the Main Market of the London Stock Exchange. The Company has submitted a draft prospectus to the FCA for review. Alex Aylen of Canaccord Genuity Hawkpoint Limited acted as financial advisor to Sivota PLC.

Apester Ltd. completed the acquisition of Sivota PLC (LSE:SIV) in a reverse merger transaction on May 13, 2022.